JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
Condition(s):Esophageal Small Cell CarcinomaLast Updated:June 27, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Esophageal Small Cell CarcinomaLast Updated:June 27, 2023Recruiting
Condition(s):Endometrial NeoplasmsLast Updated:December 11, 2012Completed
Condition(s):GI CancerLast Updated:April 17, 2019Completed
Condition(s):Adult GlioblastomaLast Updated:November 18, 2023Terminated
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:December 26, 2023Recruiting
Condition(s):HER2/Neu Negative; Recurrent Inflammatory Breast Carcinoma; Stage IV Breast Cancer; Stage IV Inflammatory Breast CarcinomaLast Updated:July 16, 2020Terminated
Condition(s):Advanced Solid Tumors; LymphomaLast Updated:February 1, 2022Completed
Condition(s):Advanced Pancreatic CarcinomaLast Updated:December 3, 2021Recruiting
Condition(s):Carcinoma, Basal CellLast Updated:November 6, 2018Completed
Condition(s):Gastric CancerLast Updated:April 29, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.